Ole Henrik has extensive experience from the pharma, biotech, diagnostics and medtech industries. Previous experience includes VP CMC in Nycomed Imaging, VP Business Development in Medinnova, CEO and COO in Clavis Pharma ASA, COO and responsible for Business Development in Weifa ASA and Chairman of Genetic Analysis AS. He was also one of the three founders of Novicus Pharma AS, acquired by Navamedic ASA in 2019. Mr. Eriksen holds a M.Sc. in Organic Chemistry from the Norwegian University of Sciences and Technology in Trondheim.